Prostate Cancer - Results from #24660

Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer - Abstract October 4, 2012

Prostate cancer detection via transrectal ultrasound biopsy: Vienna nomogram versus sextant/octant biopsy methods - Abstract October 4, 2012

Intravesical ropivacaine as a novel means of analgesia post robot assisted radical prostatectomy: A randomized, double blind, placebo controlled trial - Abstract October 4, 2012

Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: Association with outcome and predictive nomogram - Abstract October 4, 2012

Testosterone replacement therapy in the setting of prostate cancer treated with radiation - Abstract October 4, 2012

Hypofractionated prostate radiotherapy with or without conventionally fractionated nodal irradiation: Clinical toxicity observations and retrospective daily dosimetry - Abstract October 3, 2012

Robotic intra-fascial simple prostatectomy: Novel technique - Abstract October 3, 2012

Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer - Abstract October 3, 2012

Impact of robotic technique and surgical volume on the cost of radical prostatectomy - Abstract October 3, 2012

Elevated insulin and insulin resistance are associated with the advanced pathological stage of prostate cancer in Korean population - Abstract October 3, 2012

Prophylactic breast bud radiotherapy for patients taking bicalutamide: Should this still be practised for patients with prostate cancer? - Abstract October 3, 2012

Intensity-modulated radiation therapy for prostate cancer is cost effective and improves therapeutic ratio - Abstract October 3, 2012

Patient and spouse illness beliefs and quality of life in prostate cancer patients - Abstract October 3, 2012

The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage of prostate cancer: The preliminary experience - Abstract October 3, 2012

Hospitalization costs for radical prostatectomy attributable to robotic surgery - Abstract October 2, 2012

Photodynamic therapy in urology: What can we do now and where are we heading? - Abstract October 2, 2012

Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes - Abstract October 2, 2012

Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort - Abstract October 2, 2012

Pulmonary embolus as a first presentation of occult metastatic prostate cancer - Abstract October 2, 2012

Preoperative predictors of pathologic stage T2a in low-risk prostate cancer: Implications for focal therapy - Abstract October 2, 2012

Page 1234 of 1435